Actively Recruiting
Tissue Analysis of Liver Grafts as a Predictor of Transplant Outcome.
Led by IRCCS Azienda Ospedaliero-Universitaria di Bologna · Updated on 2024-12-05
200
Participants Needed
1
Research Sites
258 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Despite the good clinical results in terms of outcome with the application of HOPE prior to liver transplantation, very little is still known about the phenotypic and molecular changes that occur during perfusion/preservation during HOPE, particularly with regard to endothelial trophism and activation. Delving into these aspects would be very useful to allow personalised perfusion treatments in the future, thus improving the outcome of transplantation.
CONDITIONS
Official Title
Tissue Analysis of Liver Grafts as a Predictor of Transplant Outcome.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- For liver donors: availability of sufficient tissue for histological, immunohistochemical, and RT-PCR analysis
- HOPE performed on the liver graft prior to transplantation
- For liver recipients: availability of sufficient tissue for histological, immunohistochemical, and RT-PCR analysis
- Age 18 years or older
You will not qualify if you...
- None
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Bologna, Italy, 40138
Actively Recruiting
Research Team
F
Francecso Vasuri, MD
CONTACT
D
Deborah Malvi, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
DIAGNOSTIC
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here